CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
Personalized ADHD Medication Experimentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06305078
NCT06305078N/ACompleted

Open-Label Trial of Personalized Medication Experiments to Inform Decisions About Future Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Use

Children's Hospital Medical Center, Cincinnati·interventional·Posted Mar 12, 2024·Updated May 5, 2026

In Brief

A clinical study evaluating Personalized ADHD Medication Experiment for Attention Deficit Hyperactivity Disorder. Completed, enrolled 31 participants across 1 site.

Detailed Summary

The primary goal of the project is to test personalized medication experiments to inform decisions about future medication use. Our central hypothesis is that our intervention will lead to within subject increases in adolescent involvement in decision making and decreases in uncertainty about future medication use. The investigators view this open label trial as a pilot study to test the feasibility, acceptability, and preliminary efficacy of the medication experiment intervention and therefore warrants further testing in a future larger trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedMar 12, 2024
Enrollment StartNov 10, 2023
Primary CompletionMay 1, 2025
Study CompletionNov 1, 2025
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 2.3 years ago

Interventions

Personalized ADHD Medication Experimentother

All parent/adolescent dyads will select and complete a medication experiment.